For example, core fucosylation (CF)-glycosylation of an α-fetoprotein isoform (AFP-L3) was approved as a biomarker of hepatocellular carcinoma (HCC) by US Food and Drug Administration (FDA) [7]. This evidence concerns the gene AFP and hepatocellular carcinoma.